Suche
Filter by content type
Filter by content year
Filter by category
BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
März 16, 2020 - … BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China … BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in …
BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech’s BNT162 mRNA-based Vaccine Candidate Against SARS-CoV-2 to Hong Kong SAR and Macao SAR
August 27, 2020 - … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of …
10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region
Juli 12, 2021 - … (Nasdaq: BNTX, “BioNTech” or “the Company”) announced that Fosun Industrial Co., Limited (“Fosun Industrial”), a wholly owned subsidiary of its partner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or …
BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China
November 16, 2020 - … BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China … BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine …
BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial of Lead mRNA COVID-19 Vaccine BNT162b2 in China
November 25, 2020 - … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … mRNA COVID-19 Vaccine BNT162b2 in China … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … Lead mRNA COVID-19 Vaccine BNT162b2 in China BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial …
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
Dezember 22, 2022 - … BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China … BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination …
BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
Dezember 16, 2020 - … BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine … BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine …
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
August 5, 2020 - … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based …
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
Januar 25, 2021 - … BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine … BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong …
BioNTech and Fosun Pharma Receive Special Import Authorization in Macau for COVID-19 Vaccine
Februar 25, 2021 - … BioNTech and Fosun Pharma Receive Special Import Authorization in Macau for COVID-19 Vaccine … BioNTech and Fosun Pharma Receive Special Import Authorization in Macau for COVID-19 Vaccine BioNTech and Fosun Pharma Receive Special Import Authorization in Macau …
